Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
US7691405B2 · kind B2 · utility
41Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2008 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Feb 7, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/797
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel cationic lipids, transfection agents, microparticles, nanoparticles, and short interfering nucleic acid (siNA) molecules. Specifically, the invention relates to novel cationic lipids, microparticles, nanoparticles and transfection agents that effectively transfect or deliver short interfering nucleic acid (siNA). The compositions described herein are generally referred to as formulated molecular compositions (FMC) or lipid nanoparticles (LNP).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.